Our Weekly Windsor Hills Family Survives COVID-19 Battle Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 28 August 2020 06:00 AM America/Los_Angeles Our Weekly Windsor Hills Family Survives COVID-19 Battle Cardiosphere-derived cells (CDCs), pictured above, were intravenously given to COVID-19 patients in an experimental treatment designed to reduce inflammation. Photo by Cedars-Sinai. Our Weekly recently wrote about an experimental heart treatment developed by Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute, that helped a critically ill patient recover from COVID-19. The Our Weekly story begins when Keith Miles' wife came down with what they initially thought was a cold or allergies. Soon, Miles' own health began to decline, and by the time he went to the Ruth and Harry Roman Emergency Department, Miles was so fatigued he could barely lift a coffee mug. Cedars-Sinai physicians diagnosed him with COVID-19 and admitted him to the Cedars-Sinai Intensive Care Unit, where he received cell therapy developed by Marbán. The cell therapy saved his life, Miles told Our Weekly. Miles received CAP-1002, an experimental treatment from Capricor Therapeutics, that contains cardiosphere-derived cells grown in a laboratory from human donors' heart tissue. Research has shown that this type of cell therapy, originally created to treat inflammation in heart failure patients, could help the whole body. "Friendly fire is what's killing many coronavirus patients," Marbán said in the article. "The immune system unleashes a so-called cytokine storm into the blood - overwhelming the body with infection-fighting proteins that can trigger multiple-organ failure and death." While CAP-1002 has shown promising results, it is still considered experimental because it has not gone through a clinical trial with a control group, the Our Weekly article explained. But the treatment benefited Miles, who began recovering the first day after he received the cells. "Basically, it did save my life," Miles told Our Weekly. "And I am very thankful to the staff and to the doctors who worked on it." Marbán included Miles in a case series, published in the scientific journal Basic Research in Cardiology, which is believed to be the first peer-reviewed report describing the use of cell therapy in critically ill COVID-19 patients. Click here to read the complete story from Our Weekly. Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories HealthDay Black Women Less Likely to Get Laparoscopic Fibroid Surgeries October 07, 2022 09:00 AM America/Los_Angeles HealthDay recently interviewed Rebecca J. Schneyer, MD, a resident in the Obstetrics and Gynecology Residency Program at Cedars-Sinai, about a study she led that found Black and Hispanic women were less likely than white women to receive minimally … Read more KCRW Want New Omicron Booster Wait at Least 2 Months After Last Shot October 06, 2022 09:00 AM America/Los_Angeles KCRW program Press Play recently featured Rita Shane, PharmD, vice president and chief pharmacy officer at Cedars-Sinai, discussing who qualifies for the updated COVID-19 booster and how long patients must wait before getting the shot.The Centers … Read more ABC 7 Spider-Man Swings by 4-Year-Old Leukemia Patient s Birthday Party at Cedars-Sinai September 30, 2022 09:00 AM America/Los_Angeles ABC 7 recently profiled Cedars-Sinai patient Jabari Henley, who celebrated his fourth birthday with a special superhero at Guerin Children's newly opened inpatient facility.The Lifedriven Foundation helped throw Henley a surprise party in the Guerin … Read more Show previous items Show next items Contact the Media Team Email: [email protected] Contact Melissa VizcarraSenior Communications Specialist melissa.vizcarra@cshs.org Share this release Our Weekly Windsor Hills Family Survives COVID-19 Battle Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Visit our Facebook page (opens in new window) Follow us on Twitter (opens in new window) Visit our Youtube profile (opens in new window) (opens in new window) Latest news 07 Oct 2022 - HealthDay Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW Want New Omicron Booster Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home